Patents by Inventor Alethea Bernice Tabor

Alethea Bernice Tabor has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11098006
    Abstract: A lipid comprising a tri-chain cation having a cationic head group and three or more C7-24 hydrocarbyl groups for use in non-viral gene delivery systems, for example in the formation of lipopolyplex transfection vectors. Exceptionally good nucleic acid transfection is observed when nucleic acid and targeting peptides are formulated with the lipid of the invention (or lipid formulated with a co-lipid) into a LPD complex.
    Type: Grant
    Filed: March 10, 2017
    Date of Patent: August 24, 2021
    Assignee: RYBOQUIN COMPANY LTD
    Inventors: Helen Claire Hailes, Alethea Bernice Tabor, Mohn Firouz Mohd Mustapa, Stephen Lewis Hart, Aristides Tagalakis
  • Publication number: 20190084923
    Abstract: A lipid comprising a tri-chain cation having a cationic head group and three or more C7-24 hydrocarbyl groups for use in non-viral gene delivery systems, for example in the formation of lipopolyplex transfection vectors. Exceptionally good nucleic acid transfection is observed when nucleic acid and targeting peptides are formulated with the lipid of the invention (or lipid formulated with a co-lipid) into a LPD complex.
    Type: Application
    Filed: March 10, 2017
    Publication date: March 21, 2019
    Applicant: RYBOQUIN COMPANY LTD
    Inventors: Helen Claire HAILES, Alethea Bernice TABOR, Mohn Firouz MOHD MUSTAPA, Stephen Lewis HART, Aristides TAGALAKIS
  • Patent number: 9399016
    Abstract: The invention provides a peptide derivative of formula A-B-C wherein A is a polycationic nucleic acid-binding component; B is a spacer element peptide that is susceptible to cleavage within a cell; and C is a cell surface receptor binding component. The invention also provides a lipid derivative of general formula (I): (PEG)q-Linker-Spacer-Cationic headgroup-carbon skeleton-(hydrophobic chain)o wherein: the Linker is a group susceptible to cleavage within a cell; the Spacer is a group linking the Linker to the Cationic headgroup; q denotes the number of PEG chains and q=1, 2 or 3; o denotes the number of hydrophobic chains and o=1, 2 or 3; the carbon skeleton is a group linking the hydrophobic chains to the cationic headgroup. The peptide and lipid derivatives find use in non-viral gene delivery systems.
    Type: Grant
    Filed: May 30, 2007
    Date of Patent: July 26, 2016
    Assignee: UCL BUSINESS PLC
    Inventors: Stephen Lewis Hart, Stephanie Grosse, Alethea Bernice Tabor, John Bosco Wong, Martin Elbs, Helen Claire Hailes, Mohd Firouz Mohd Mustapa
  • Publication number: 20100184831
    Abstract: The invention provides a peptide derivative of formula A-B-C wherein A is a polycationic nucleic acid-binding component; B is a spacer element peptide that is susceptible to cleavage within a cell; and C is a cell surface receptor binding component. The invention also provides a lipid derivative of general formula (I): (PEG)q-Linker-Spacer-Cationic headgroup-carbon skeleton-(hydrophobic chain)o wherein: the Linker is a group susceptible to cleavage within a cell; the Spacer is a group linking the Linker to the Cationic headgroup; q denotes the number of PEG chains and q=1, 2 or 3; o denotes the number of hydrophobic chains and o=1, 2 or 3; the carbon skeleton is a group linking the hydrophobic chains to the cationic headgroup. The peptide and lipid derivatives find use in non-viral gene delivery systems.
    Type: Application
    Filed: May 30, 2007
    Publication date: July 22, 2010
    Inventors: Stephen Lewis Hart, Stephanie Grosse, Alethea Bernice Tabor, John Bosco Wong, Martin Elbs, Helen Claire Hailes, Mohd Firouz Mohd Mustapa